BioHorizons, a dental implant company and subsidiary of Henry Schein Inc., celebrated its 30th anniversary at its Birmingham headquarters.
Founded at the University of Alabama at Birmingham Office for the Advancement of Developing Industries in 1994, BioHorizons has expanded its footprint over the past three decades. Today, the company has offices in the U.S., Canada, Chile, Mexico, UK, Spain, Portugal and Italy, employing more than 700 team members. Its global distribution center is located at its Birmingham headquarters, occupying more than 125,000 square feet, and a 50,000-square-foot manufacturing facility is located in Southern California.
“In celebration of BioHorizon’s 30th anniversary, we reflect on our unwavering dedication to science, innovation and service, as well as our rich legacy of groundbreaking dental implant designs and tissue regeneration products,” said Steve Boggan, BioHorizons president and CEO. “We are incredibly grateful to our team members for their unwavering commitment to our mission. Our roots in the Birmingham community have been integral to our success, and we look forward to continuing to advance dental implant technology for the benefit of our customers and patients worldwide.”
BioHorizons joined Henry Schein Inc., a provider of health care solutions to office-based dental and medical practitioners, through an initial investment in 2013, followed by a full acquisition in 2018.
BioHorizons Camlog supplies dental implant systems, restorative components, a comprehensive line of biologics products and digital solutions.
BioHorizons.com